Immix Biopharma Investor Presentation Deck slide image

Immix Biopharma Investor Presentation Deck

World-Class Team Leadership Board of Directors Members Scientific Advisory Board Members Ilya Rachman, MD, PhD Chief Executive Officer Cedars Sinai UCLA HealthEFERTY OF MEDICINE UIC COLLEGE OF AT CHICAGO Helen Adams, CPA Former Prometheus Biosciences Board Member Prometheus Deloitte. Biosciences Henry A. McKinnell, PhD Former Pfizer, Inc. Chief Executive Officer Pfizer MOODY'S Heather Landau, MD (MSK) Memorial Sloan Kettering Cancer Center Larry Norton, MD • SVP, Office of the President, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center Director, Amyloidosis Program Goldman COLUMBIA UNIVERSITY Sachs IN THE CITY OF NEW YORK JOHN WAYNE CANCER INSTITUTE PrinceSat J Gabriel Morris, BA Chief Financial Officer . Founder, Sarcoma Oncology Research Center Sant Chawla, MD Johnson & Johnson THE UNIVERSITY OF TEXAS MD Anderson Cancer Center Magda Marquet, PhD ALMA Life Sciences ALTHEA Mary Sue Coleman, Ph.D Former Johnson & Johnson Board Member ALMA Life Sciences M VIKTIRAN AstraZeneca Suzanne Lentzsch, MD, PHD (Columbia) do COLUMBIA THE UNIVERSITY OF TEXAS MD Anderson Cancer Center Razelle Kurzrock, MD Chief, Oncology/ Hematology at UCSD School of Medicine UC San Diego School of Medicine Graham Ross, MBChB, FFPM Chief Medical Officer Roche gsk • KKR PRISMA Jane Buchan, PhD CEO, Martlet Asset Management J.P.Morgan Jeffrey H. Cooper, MBA Former BioMarin Chief Financial Officer BIOMARIN Director, Multiple Myeloma and Amyloidosis COLUMBIA UNIVERSITY HERBERT IRVING COMPREHENSIVE CANCER CENTER University Hospitals Bristol Drexel NHS Foundation Trust Galit Lahav, PhD Chair, Department of Systems Biology at Harvard Medical School HARVARD David Marks, MBBS, PhD Chief Medical Officer, Cell Therapy TECARTUS® Kite/Gilead NHS Pfizer KYMRIAH® Novartis MEDICAL SCHOOL Michaela Liedtke, MD (Stanford) RAYLIANT Gary Schiller, MD • UCLA Professor of Oncology UCLA Health ●●● IMMİX S BIOPHARMA Ave Gerhard Bauer Head of Cell Therapy Manufacturing Jason Hsu, PhD Founder & Chairman, Rayliant Global Advisors Stanford MEDICINE UCDAVIS American Society UNIVERSITY OF CUENT of Gene Cell Therapy research affiliates Edward J. Borkowski, CPA MBA Former Mylan Chief Financial Officer Mylan® Co-Director, Stanford Amyloid Center George Sledge, MD • Professor, former Chief, Oncology Division, Stanford Medicine Stanford MEDICINE 4
View entire presentation